Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 1 feed behind: Insider filings, 3 days · Every feed →

All 15Congress 0Executive branch 0Insiders 15
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

SCTX · Insiders · $250K+ · 15 trades

Trades
15
Buys 15 · Sells 0
People
12
Stocks
1
Disclosed value
$183M
range midpoints · Congress & executive
Filed late
0
  1. ▲ BUYAH Bio Fund II, L.P. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  2. ▲ BUYBenjamin A Horowitz 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  3. ▲ BUYAH Bio Fund III, L.P. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  4. ▲ BUYAH Equity Partners Bio II, L.L.C. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  5. ▲ BUYOrbiMed Capital GP VIII LLC DirectorSCTX Scribe Therapeutics, Inc.$15Mdisclosed Jul 29 · filed 2 days after the trade
  6. ▲ BUYOrbimed Advisors LLC DirectorSCTX Scribe Therapeutics, Inc.$15Mdisclosed Jul 29 · filed 2 days after the trade
  7. ▲ BUYAH Equity Partners Bio III, L.L.C. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  8. ▲ BUYCarl L Gordon DirectorSCTX Scribe Therapeutics, Inc.$15Mdisclosed Jul 29 · filed 2 days after the trade
  9. ▲ BUYMarc L Andreessen 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  10. ▲ BUYAvoro Capital Advisors LLC DirectorSCTX Scribe Therapeutics, Inc.$1.1Mdisclosed Jul 28 · filed 4 days after the trade
  11. ▲ BUYAvoro Ventures LLC DirectorSCTX Scribe Therapeutics, Inc.$1.1Mdisclosed Jul 28 · filed 4 days after the trade
  12. ▲ BUYBehzad Aghazadeh DirectorSCTX Scribe Therapeutics, Inc.$35Mdisclosed Jul 28 · filed 4 days after the trade
  13. ▲ BUYAvoro Capital Advisors LLC DirectorSCTX Scribe Therapeutics, Inc.$35Mdisclosed Jul 28 · filed 4 days after the trade
  14. ▲ BUYBehzad Aghazadeh DirectorSCTX Scribe Therapeutics, Inc.$1.1Mdisclosed Jul 28 · filed 4 days after the trade
  15. ▲ BUYAvoro Ventures LLC DirectorSCTX Scribe Therapeutics, Inc.$35Mdisclosed Jul 28 · filed 4 days after the trade